| CVLFX | VIVAX | CVLFX / VIVAX | |
| Total Expense Ratio | 1.75 | 0.17 | 1,029% |
| Annual Report Gross Expense Ratio | 3.45 | 0.17 | 2,029% |
| Fund Existence | 14 years | 34 years | - |
| Gain YTD | 19.192 | 15.121 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 32.8M | 254B | 0% |
| Annual Yield % from dividends | 0.66 | 1.74 | 38% |
| Returns for 1 year | 27.38 | 24.27 | 113% |
| Returns for 3 years | 35.99 | 50.22 | 72% |
| Returns for 5 years | 19.23 | 58.84 | 33% |
| Returns for 10 years | 45.79 | 154.96 | 30% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LAVTX | 17.89 | 0.03 | +0.17% |
| Lord Abbett Fundamental Equity R5 | |||
| RYDVX | 2.63 | N/A | N/A |
| Royce Smid-Cap Total Return Service | |||
| BGORX | 24.61 | -0.16 | -0.65% |
| BlackRock Advantage International R | |||
| ERHSX | 14.60 | -0.17 | -1.15% |
| Eaton Vance Worldwide Health Sci R | |||
| MSSMX | 10.76 | -0.13 | -1.19% |
| Morgan Stanley Inst Inception A | |||